RK
Raushan Kumar
About Raushan Kumar
Data last updated:
Raushan Kumar is a Director at Aviomark Pharmaceuticals Private Limited (since 2020) and Director at Aviolin Pharmaceuticals Private Limited (since 2025). The companies operate in Trading and Pharma. The largest current company by reported revenue is Aviomark Pharmaceuticals Private Limited at ₹11.1 Lakh (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Aug 2020 | 2017 | ₹11.1 Lakh (FY 2022) | Active | |
| Director | 16 Sep 2025 | 2025 | Active |
Board colleagues of Raushan Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nitu Kumari | 07710489 | Aviomark Pharmaceuticals Private Limited | Director |
| Anshu Kumari | 11302108 | Aviolin Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raushan Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raushan Kumar
Raushan Kumar currently holds 2 directorships: Aviomark Pharmaceuticals Private Limited (Director, since 17 Aug 2020, revenue ₹11.1 Lakh (FY 2022)); Aviolin Pharmaceuticals Private Limited (Director, since 16 Sep 2025).
Raushan Kumar was first appointed on 17 Aug 2020 as Director at Aviomark Pharmaceuticals Private Limited. The most recent appointment on record is 16 Sep 2025 at Aviolin Pharmaceuticals Private Limited.
The current boards of Raushan Kumar's companies include Nitu Kumari (Aviomark Pharmaceuticals Private Limited), Anshu Kumari (Aviolin Pharmaceuticals Private Limited).